Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Full Validation of Pooled Antibiotic Susceptibility Testing Using CLSI Methods and Performance Criteria in UTI Pathogens.

Antibiotics (Basel, Switzerland)·2025
Same author

Pooled Antibiotic Susceptibility Testing for Polymicrobial UTI Performs Within CLSI Validation Standards.

Antibiotics (Basel, Switzerland)·2025
Same author

Pooled Antibiotic Susceptibility Testing Performs Within CLSI Standards for Validation When Measured Against Broth Microdilution and Disk Diffusion Antibiotic Susceptibility Testing of Cultured Isolates.

Antibiotics (Basel, Switzerland)·2025
Same author

Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014.

Annals of internal medicine·2017
Same author

The Burden of Hepatitis C Infection-Related Liver Fibrosis in the United States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2016
Same author

In Reference to: Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2016

Related Experiment Video

Updated: May 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Testing and reporting practices for improved management of hepatitis C.

Rick L Pesano1

  • 1Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, USA. rick.l.pesano@questdiagnostics.com

Antiviral Therapy
|January 17, 2013
PubMed
Summary

Improving surveillance for chronic Hepatitis C Virus (HCV) infection in the US requires better test reporting and physician education. This will enhance early identification and timely treatment for patients.

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: May 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

  • Hepatology
  • Public Health Surveillance
  • Infectious Disease Management

Background:

  • Chronic Hepatitis C Virus (HCV) infection presents ongoing challenges in patient management.
  • Recent diagnostic and therapeutic advancements offer improved options for physicians.
  • Realizing the full potential of these advancements in the US is hindered by suboptimal surveillance.

Purpose of the Study:

  • To highlight the necessity of enhanced surveillance for chronic HCV infection in the United States.
  • To propose strategies for improving the identification and management of new HCV cases.
  • To emphasize the role of reporting standards and physician education in optimizing patient outcomes.

Main Methods:

  • The study emphasizes the need for establishing comprehensive test reporting requirements.
  • It advocates for ensuring physicians understand appropriate test ordering and interpretation.
  • The approach focuses on harmonizing reporting standards and implementing physician education programs.

Main Results:

  • Improved surveillance through comprehensive reporting and physician education is crucial for maximizing new treatment potentials.
  • Enhanced identification of infected individuals is a direct outcome of better surveillance.
  • Increased timeliness of medical interventions for HCV patients is anticipated.

Conclusions:

  • Harmonized reporting standards and physician education are essential for effective chronic HCV management.
  • These combined strategies will lead to better identification of infected individuals.
  • The ultimate goal is to improve the timeliness and effectiveness of medical interventions for HCV patients.